Entourage Health Launches Dime Bag® Branded Pre-Rolls and Introduces Syndicate: A Collective of Craft Cannabis 

8 months ago

Entourage addresses market demand for affordable premium cannabis with new brand, Dime Bag® The Company announces Syndicate, a collective of exclusive…

MiNK Therapeutics to Participate in September Investor Conferences

8 months ago

NEW YORK, Aug. 24, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics (Nasdaq: INKT), a clinical-stage biopharmaceutical company specializing in the discovery,…

Ascendis Pharma A/S Announces Three Upcoming Investor Presentations

8 months ago

COPENHAGEN, Denmark, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that Jan Mikkelsen, President &…

Verrica Pharmaceuticals Announces First Sale of YCANTH™ to FFF Enterprises

8 months ago

YCANTH™ is the first and only FDA-approved treatment for molluscum, a highly contagious viral skin infection affecting approximately 6 million…

Smart for Life Appoints Stuart Benson, JD to the Company’s Newly Launched Advisory Board

8 months ago

Benson Provides Deep Nutraceutical Industry Business Experience to the Highly Diversified BoardMIAMI, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Smart for…

Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand

8 months ago

TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged with TRxADE HEALTH, Inc.…

AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache

8 months ago

IRVINE, Calif., Aug. 24, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON, AEON WS), a…

Alpha Tau Medical to Participate in September Investor Conferences

8 months ago

JERUSALEM, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ: DRTS, DRTSW), the…

Recce Pharmaceuticals Doses Patients in Phase I/II Clinical Trial of RECCE® 327 for Diabetic Foot Infections

8 months ago

Patients dosed in Phase I/II trial, evaluating RECCE® 327 (R327) in patients with diabetic foot infections (DFI), currently the largest…

aTyr Pharma to Present at the H.C. Wainwright 25th Annual Global Investment Conference

8 months ago

SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery…